HYTN Innovations has announced the receipt of initial orders and import permits from the UK's 4C Labs. This allows HYTN to begin exporting cannabis-based pharmaceuticals to the UK under the company's recently established agreements
Elliot McKerr, Chief Executive Officer of HYTN said: "We are thrilled to take this next step with 4C Labs."
For more information:
HYTN Innovations
hytn.ca/
4C Labs
4clabs.co/
